Nevada Annual Report
ActiveIn good standing

amylyx pharmaceuticals, inc.

Foreign Corporation · Entity Number E22927752022-9 · NV Business ID NV20222440173

Formed
April 29, 2022
Annual List
Due by April 30, 2027
Managed by
Not on file

Record

Entity Number
E22927752022-9
NV Business ID
NV20222440173
Entity type
Foreign Corporation
Home jurisdiction
Delaware
Formed
April 29, 2022
Authorized capital
$310,000
Record as of
September 17, 2026

Principal office

Not on file

Mailing address

Not on file

Officers, managers, and members

NameRoleAddress
Gina MazzarielloSecretary55 Cambridge Parkway, Suite 6W · Cambridge, MA 02138
Daphne QuimiDirector55 Cambridge Parkway, Suite 6W · Cambridge, MA 02138
Karen Firestone· 2 entitiesDirector55 Cambridge Parkway, Suite 6W · Cambridge, MA 02138
Justin KleePresident55 Cambridge Parkway, Suite 6W · Cambridge, MA 02138
James FratesTreasurer55 Cambridge Parkway, Suite 6W · Cambridge, MA 02138
Joshua Cohen· 11 entitiesDirector55 Cambridge Parkway, Suite 6W · Cambridge, MA 02138
George M Milne Jr. Ph.D.Director55 Cambridge Parkway, Suite 6W · Cambridge, MA 02138
Justin KleeDirector55 Cambridge Parkway, Suite 6W · Cambridge, MA 02138
Paul Fonteyne· 2 entitiesDirector55 Cambridge Parkway, Suite 6W · Cambridge, MA 02138
Joshua Cohen(CEO)President55 Cambridge Parkway, Suite 6W · Cambridge, MA 02138
Bernhardt Zeiher, MDDirector55 Cambridge Parkway, Suite 6W · Cambridge, MA 02138

Information is drawn from the public record and may lag the state by up to one day. NVAnnualReport.com is not affiliated with the Secretary of State of Nevada.